Nuo Therapeutics

Nuo Therapeutics is a U.S.-based biomedical company founded in 2007, operating in the regenerative medicine and wound care sectors. It has reached the commercial stage with its lead product, Aurix, a personalized hematogel therapy derived from a patient's blood. The company's strategy centers on leveraging a patient's innate biology to improve healing outcomes while aiming to demonstrate value within the health economic system. Its operations are headquartered in Gaithersburg, Maryland.

Autologous biodynamic therapy platform utilizing patient-derived platelets and plasma to create a hematogel that stimulates the body's innate healing processes.

Nuo competes in the advanced wound care market against other autologous platelet-rich plasma (PRP) products, allogeneic cellular and tissue-based products, bioengineered skin substitutes, and advanced dressings. Differentiation requires demonstrating clinical superiority, ease of use, and cost-effectiveness.